Medios Investor Relations Material
Latest events
Q2 2025
Medios
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Medios AG
Access all reports
Medios AG is a Germany-based company that engages in the wholesale of specialty pharmaceutical drugs. It offers a range of products, such as Asacol, Dornase alfa, Doxil, Fludara, Flumadine, and Multiplix. The company distributes products to hospitals and other health care providers. It also provides pharmacy services in hospitals and other health care institutions. The company was founded in 2016 and is based in Berlin, Germany.
Key slides for Medios AG
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ILM1
Country
🇩🇪 Germany